Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

ators on a submission to gain regulatory approval for Gleevec as adjuvant treatment for GIST."

Following the recommendation of a data monitoring committee, the study will be closed and patients in the study who are currently being treated with placebo may choose to receive one year of Gleevec.

In the study, patients were randomized to one of two treatment arms. Neither the patients nor physicians knew which treatment the patients were receiving. One patient group received Gleevec at a dose of 400 milligrams per day for one year, while the second group received placebo for one year. According to the study design, patients who developed a recurrence of their cancer while on a study therapy were unblinded to their treatment assignment. Those receiving placebo subsequently received Gleevec, while those already given Gleevec continued with this therapy but at a higher dose. Study results will be presented at a forthcoming scientific meeting.

Gastrointestinal stromal tumors (GIST) belong to a group of cancers known as soft tissue sarcomas that usually arise from the intestinal tract, with the most common site being the stomach followed by the small intestine. The incidence of GIST is estimated to be 4,500-6,000 new cases per year in the US (15-20 cases per million population), of which more than 90% are kit-positive.

Investigators in the NCI study reported that Gleevec therapy was well tolerated by most patients, with side effects similar to those observed in other clinical trials with Gleevec. These include nausea, diarrhea and swelling (edema). Information on more than 600 patients enrolled in the study was used in the analysis.

About Gleevec

Gleevec(R) (imatinib mesylate) is indicated for the treatment of patients with Kit (CD117)-positive unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST). The effectiveness of Gleevec in GIST is based on objective response rate. There are no controlled trials demon
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5hkm2f/medical_oxygen ) has ... - Global Strategic Business Report" report to their ... for Medical Oxygen Systems in US$ Thousands by the ... & Regulators, and Oxygen Conserving Devices. The report provides ... , Japan , ...
(Date:4/17/2015)... 17, 2015 Steven Rash , the CEO ... its operating subsidiary American Seed & Oil Company, presented ... investors yesterday in New York City.  Mr. Rash,s presentation ... American Seed & Oil Company has recently announced the ... Hemp Seed Foods , the EpiVape , and ...
(Date:4/17/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ) has ... Pharma in 2014 - a Perspective of Diabetes Patient ... This independent study, funded by the author, ... interest in diabetes on the corporate reputation of 14 ... a whole) in 2014. The results from the respondent ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... & NEW DELHI, India--(BUSINESS WIRE)--Jun 21, 2007,- The ... today announced that Phase 3 research,related to its ... published in the current issue of The,New England ... the medicine paromomycin is safe, effective, and well ...
... MRSA,in Healthcare Facilities, WASHINGTON, June 21, 2007 /PRNewswire-USNewswire/ -- The,following ... WHAT:, -- First nationwide study of the ... aureus (MRSA), a virulent multi-drug resistant organism, ... -- MRSA prevalence study findings significantly exceed previous estimates, ...
Cached Medicine Technology:Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2
(Date:4/17/2015)... April 17, 2015 John Evans, a ... on the Patio from 2 p.m. to 3 p.m. ... at 1320 Executive Ct. in Pekin, Illinois, serves older ... need some help to maintain their independence. , Becky ... tropical treats will be served during the luau. , ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at Connerton ... all selected as Top Workplaces in Tampa Bay. ... ranked number one for large businesses according to the ... partnership with an independent research firm. Florida Hospital Wesley ... in October of 2012 with a vision of excellence ...
(Date:4/17/2015)... 17, 2015 Representatives Jim Himes (D-CT) ... Treatment Act HR 1849 in congress on April 16, ... treatment for patients with the genetic disease. , ... would be the first to create a federally led ... of hereditary hemorrhagic telangiectasia. This would effectively prevent premature ...
(Date:4/17/2015)... York, New York (PRWEB) April 17, 2015 ... that allege this class of prescription medications ... a heart attack, stroke or other life-threatening cardiovascular ... underway in U.S. District Court, Northern District of ... by the U.S. Judicial Panel on Multidistrict Litigation ...
(Date:4/17/2015)... 2015 Connie Casad, M.D., a well-known ... advocate with 30 years of practice experience in Dallas, ... level of service for her patients with the availability ... recommended wellness books with a brief synopsis on each ... her interest in providing this service, Dr. Casad said, ...
Breaking Medicine News(10 mins):Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2
... internally dynamized anterior cervical plating system offers zero-step ... Spine announces the nationwide market introduction of the ... which gained 510(k) approval from the U.S. Food ... an internally dynamizing anterior cervical plating ...
... Activeion Cleaning Solutions, LLC is ... its commitment to environmental sustainability by joining ... and businesses in the health care field ... footprints.(Logo: http://www.newscom.com/cgi-bin/prnh/20090519/MN19118LOGO )Practice Greenhealth provides ...
... 2009 CytoFlora decreases IgA and IgM antibodies to ... LAGUNA HILLS, Calif., May 19 It is believed that ... gastrointestinal dysfunction. BioRay,s new cell wall lysed probiotic, ... to correct microbial imbalances, drive pathogens out of the gastrointestinal ...
... crisis highlighted an unforseen by-product of the looming fuel ... such as plastics that society takes for granted but ... oil. Scientists are looking to microorganisms to pick ... according to research presented today at the 109th General ...
... See Clearly Now" Helps Readers Seek Deeper Meaning in ... Mary Soliel,s debut non-fiction, "I Can See Clearly Now: ... "Indie" Finalist in the "Spirituality" category of the 2009 ... Her book was previously selected by USA Book News ...
... New Life Agency filed suit against Beitler Services on ... out of a previous contractual relationship between New Life ... Once New Life Agency assumed direct management for claims ... Surrogate Maternity and Cycle Medical Plan(R), clients and surrogates.In ...
Cached Medicine News:Health News:Activeion Cleaning Solutions, LLC Joins National Health Organization Supporting Environmental Practices 2Health News:Activeion Cleaning Solutions, LLC Joins National Health Organization Supporting Environmental Practices 3Health News:BioRay's CytoFlora Reduces Digestive and Behavioral Issues in Autistic Children 2Health News:Microscopic manufacturers produce eco-friendly plastics 2Health News:Microscopic manufacturers produce eco-friendly plastics 3Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 2Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 3Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 3
... The PipetBoy Pipettor is light as a feather ... aspiration speed can be continuously adjusted. The pipette ... be autoclaved. Two dosing knobs enable fine dosing ... plastic an/or glass pipettes from 0.1 to 100 ...
Precise, safe, and fatigue-free series pipetting using graduated pip...
Inquire...
Inquire...
Medicine Products: